Rank | Gene Set | Z-score |
---|---|---|
1 | exocrine pancreas development (GO:0031017) | 4.55460606 |
2 | intestinal cholesterol absorption (GO:0030299) | 4.43969539 |
3 | cell adhesion mediated by integrin (GO:0033627) | 4.10808145 |
4 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.90383185 |
5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.82765600 |
6 | L-phenylalanine catabolic process (GO:0006559) | 3.82765600 |
7 | iron ion import (GO:0097286) | 3.80605011 |
8 | protein retention in ER lumen (GO:0006621) | 3.62051901 |
9 | skin morphogenesis (GO:0043589) | 3.59772323 |
10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.45848657 |
11 | L-phenylalanine metabolic process (GO:0006558) | 3.45848657 |
12 | COPI coating of Golgi vesicle (GO:0048205) | 3.45472897 |
13 | Golgi transport vesicle coating (GO:0048200) | 3.45472897 |
14 | gonadal mesoderm development (GO:0007506) | 3.34237688 |
15 | negative regulation of protein activation cascade (GO:2000258) | 3.13007238 |
16 | negative regulation of complement activation (GO:0045916) | 3.10044549 |
17 | cysteine metabolic process (GO:0006534) | 3.09211236 |
18 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.98024305 |
19 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.97172697 |
20 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.96740807 |
21 | alpha-linolenic acid metabolic process (GO:0036109) | 2.95979222 |
22 | cellular modified amino acid catabolic process (GO:0042219) | 2.88859235 |
23 | negative regulation of fatty acid transport (GO:2000192) | 2.82569991 |
24 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.81404482 |
25 | transcytosis (GO:0045056) | 2.79058195 |
26 | L-serine transport (GO:0015825) | 2.77126328 |
27 | desmosome organization (GO:0002934) | 2.75250501 |
28 | chondrocyte development (GO:0002063) | 2.74866143 |
29 | aromatic amino acid family catabolic process (GO:0009074) | 2.74165014 |
30 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.73286138 |
31 | positive regulation of nuclease activity (GO:0032075) | 2.72677037 |
32 | sulfur amino acid catabolic process (GO:0000098) | 2.71180134 |
33 | ER overload response (GO:0006983) | 2.70126498 |
34 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.69745317 |
35 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.68594811 |
36 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.67524951 |
37 | COPII vesicle coating (GO:0048208) | 2.67383697 |
38 | positive regulation of muscle hypertrophy (GO:0014742) | 2.64584225 |
39 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.64584225 |
40 | protein carboxylation (GO:0018214) | 2.62001583 |
41 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.62001583 |
42 | digestion (GO:0007586) | 2.61090507 |
43 | hypotonic response (GO:0006971) | 2.58405883 |
44 | cellular response to unfolded protein (GO:0034620) | 2.58221777 |
45 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.58091550 |
46 | ER-nucleus signaling pathway (GO:0006984) | 2.57999820 |
47 | bile acid biosynthetic process (GO:0006699) | 2.56045275 |
48 | coenzyme catabolic process (GO:0009109) | 2.54249992 |
49 | oligosaccharide catabolic process (GO:0009313) | 2.53497655 |
50 | apoptotic cell clearance (GO:0043277) | 2.52709547 |
51 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.52558405 |
52 | serine transport (GO:0032329) | 2.50228023 |
53 | homocysteine metabolic process (GO:0050667) | 2.48331510 |
54 | membrane protein ectodomain proteolysis (GO:0006509) | 2.48331341 |
55 | intestinal absorption (GO:0050892) | 2.48227915 |
56 | glutamate metabolic process (GO:0006536) | 2.47474715 |
57 | reverse cholesterol transport (GO:0043691) | 2.45058814 |
58 | high-density lipoprotein particle remodeling (GO:0034375) | 2.44286969 |
59 | * response to endoplasmic reticulum stress (GO:0034976) | 2.44198574 |
60 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.42491769 |
61 | glycolipid catabolic process (GO:0019377) | 2.42402088 |
62 | complement activation, classical pathway (GO:0006958) | 2.42292415 |
63 | macroautophagy (GO:0016236) | 2.42122255 |
64 | 4-hydroxyproline metabolic process (GO:0019471) | 2.41469574 |
65 | keratan sulfate catabolic process (GO:0042340) | 2.41199073 |
66 | cellular response to ethanol (GO:0071361) | 2.41063079 |
67 | protein targeting to Golgi (GO:0000042) | 2.40391110 |
68 | regulation of nuclease activity (GO:0032069) | 2.39543120 |
69 | cellular response to topologically incorrect protein (GO:0035967) | 2.38425295 |
70 | negative regulation of humoral immune response (GO:0002921) | 2.38421162 |
71 | positive regulation of extracellular matrix organization (GO:1903055) | 2.37680088 |
72 | negative regulation of digestive system process (GO:0060457) | 2.35912974 |
73 | wound healing, spreading of epidermal cells (GO:0035313) | 2.35527655 |
74 | positive regulation of receptor recycling (GO:0001921) | 2.35516817 |
75 | nerve growth factor signaling pathway (GO:0038180) | 2.35015816 |
76 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.34549433 |
77 | glycosphingolipid catabolic process (GO:0046479) | 2.34394522 |
78 | sterol catabolic process (GO:0016127) | 2.32998665 |
79 | cholesterol catabolic process (GO:0006707) | 2.32998665 |
80 | short-chain fatty acid metabolic process (GO:0046459) | 2.32807670 |
81 | negative regulation of fibrinolysis (GO:0051918) | 2.32470454 |
82 | valine metabolic process (GO:0006573) | 2.32079976 |
83 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.31698719 |
84 | positive regulation of coagulation (GO:0050820) | 2.29994971 |
85 | regulation of phospholipase A2 activity (GO:0032429) | 2.28502160 |
86 | aspartate family amino acid catabolic process (GO:0009068) | 2.27909854 |
87 | bile acid metabolic process (GO:0008206) | 2.25767578 |
88 | plasma lipoprotein particle clearance (GO:0034381) | 2.25678581 |
89 | surfactant homeostasis (GO:0043129) | 2.24443236 |
90 | establishment of protein localization to Golgi (GO:0072600) | 2.24426460 |
91 | complement activation, alternative pathway (GO:0006957) | 2.24270993 |
92 | lysine catabolic process (GO:0006554) | 2.23949484 |
93 | lysine metabolic process (GO:0006553) | 2.23949484 |
94 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.23296205 |
95 | positive regulation of blood coagulation (GO:0030194) | 2.22676949 |
96 | positive regulation of hemostasis (GO:1900048) | 2.22676949 |
97 | Golgi organization (GO:0007030) | 2.21839068 |
98 | glyoxylate metabolic process (GO:0046487) | 2.21724517 |
99 | locomotory exploration behavior (GO:0035641) | 2.21443084 |
100 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.21156936 |
101 | endoplasmic reticulum organization (GO:0007029) | 2.20766435 |
102 | membrane raft organization (GO:0031579) | 2.20753362 |
103 | collagen fibril organization (GO:0030199) | 2.20530958 |
104 | hemidesmosome assembly (GO:0031581) | 2.20350425 |
105 | import into cell (GO:0098657) | 2.19804547 |
106 | vesicle coating (GO:0006901) | 2.19729735 |
107 | negative regulation of anoikis (GO:2000811) | 2.19237481 |
108 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.18996847 |
109 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.18458557 |
110 | cholesterol transport (GO:0030301) | 2.17992701 |
111 | sterol transport (GO:0015918) | 2.17992701 |
112 | complement activation (GO:0006956) | 2.17980556 |
113 | ceramide catabolic process (GO:0046514) | 2.17085960 |
114 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.16213853 |
115 | urea cycle (GO:0000050) | 2.16053851 |
116 | urea metabolic process (GO:0019627) | 2.16053851 |
117 | cholesterol efflux (GO:0033344) | 2.15964621 |
118 | protein hydroxylation (GO:0018126) | 2.15847947 |
119 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.14387262 |
120 | regulation of fibrinolysis (GO:0051917) | 2.14053433 |
121 | phospholipid translocation (GO:0045332) | 2.13753810 |
122 | lipid translocation (GO:0034204) | 2.13753810 |
123 | peptidyl-proline hydroxylation (GO:0019511) | 2.13154992 |
124 | regulation of cholesterol homeostasis (GO:2000188) | 2.12968395 |
125 | sphingomyelin metabolic process (GO:0006684) | 2.12748168 |
126 | mannose metabolic process (GO:0006013) | 2.12684362 |
127 | regulation of protein activation cascade (GO:2000257) | 2.11867826 |
128 | endodermal cell differentiation (GO:0035987) | 2.11198648 |
129 | protein activation cascade (GO:0072376) | 2.11116973 |
130 | alanine transport (GO:0032328) | 2.09794919 |
131 | mRNA modification (GO:0016556) | 2.09018245 |
132 | tyrosine metabolic process (GO:0006570) | 2.08822911 |
133 | cellular glucuronidation (GO:0052695) | 2.08634671 |
134 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.08565043 |
135 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.08334646 |
136 | phospholipid homeostasis (GO:0055091) | 2.07719975 |
137 | plasma lipoprotein particle remodeling (GO:0034369) | 2.07639986 |
138 | protein-lipid complex remodeling (GO:0034368) | 2.07639986 |
139 | macromolecular complex remodeling (GO:0034367) | 2.07639986 |
140 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.07613769 |
141 | cellular potassium ion homeostasis (GO:0030007) | 2.07129471 |
142 | protein localization to endosome (GO:0036010) | 2.06697109 |
143 | detection of molecule of bacterial origin (GO:0032490) | 2.05967730 |
144 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.05423322 |
145 | cellular ketone body metabolic process (GO:0046950) | 2.04658323 |
146 | signal peptide processing (GO:0006465) | 2.04557224 |
147 | regulation of plasminogen activation (GO:0010755) | 2.03836351 |
148 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.03228868 |
149 | cellular amino acid catabolic process (GO:0009063) | 2.02814377 |
150 | membrane lipid catabolic process (GO:0046466) | 2.02110903 |
151 | fibrinolysis (GO:0042730) | 2.02015599 |
152 | kynurenine metabolic process (GO:0070189) | 2.01646061 |
153 | epoxygenase P450 pathway (GO:0019373) | 2.01061301 |
154 | glycine transport (GO:0015816) | 2.01031169 |
155 | regulation of ARF protein signal transduction (GO:0032012) | 2.00792901 |
156 | creatine metabolic process (GO:0006600) | 2.00731752 |
157 | negative regulation of lipid transport (GO:0032369) | 2.00583872 |
158 | hormone catabolic process (GO:0042447) | 2.00277894 |
159 | sphingosine metabolic process (GO:0006670) | 2.00017106 |
160 | regulation of complement activation (GO:0030449) | 1.99884195 |
161 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 1.99527702 |
162 | response to unfolded protein (GO:0006986) | 1.99135066 |
163 | regulation of beta-amyloid formation (GO:1902003) | 1.98965207 |
164 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 1.98879707 |
165 | dicarboxylic acid catabolic process (GO:0043649) | 1.98877041 |
166 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 1.98802642 |
167 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 1.97936796 |
168 | response to methylmercury (GO:0051597) | 1.97147508 |
169 | positive regulation of lipid catabolic process (GO:0050996) | 1.96918861 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.86316020 |
2 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.51585105 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.25265357 |
4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.85598738 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.64978701 |
6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.50284566 |
7 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.31194121 |
8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.29098128 |
9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.09081204 |
10 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.99842805 |
11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.98339060 |
12 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.96572800 |
13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.90528037 |
14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.81452529 |
15 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.78992149 |
16 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.77644567 |
17 | CJUN_26792858_Chip-Seq_BT549_Human | 1.74623372 |
18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74499909 |
19 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.69106844 |
20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.68946296 |
21 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.66701948 |
22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.66475480 |
23 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.66466502 |
24 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.65012985 |
25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.64272612 |
26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.63865775 |
27 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.63491920 |
28 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.61502896 |
29 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.60619052 |
30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.55906011 |
31 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.55000837 |
32 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.54861894 |
33 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.53767998 |
34 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.52580585 |
35 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.52533208 |
36 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.51475946 |
37 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.51475946 |
38 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.51458455 |
39 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.49157575 |
40 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.49156515 |
41 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.48356964 |
42 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.48172767 |
43 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.48172767 |
44 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.46878116 |
45 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.45670786 |
46 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.45670786 |
47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.43202649 |
48 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.41276091 |
49 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.41119329 |
50 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.41036641 |
51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.40090424 |
52 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.38745563 |
53 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.37477590 |
54 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.36908825 |
55 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.36386720 |
56 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.35820187 |
57 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.35656158 |
58 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.35375937 |
59 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.34782924 |
60 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.33653230 |
61 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.33038094 |
62 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29992709 |
63 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.29353540 |
64 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27543823 |
65 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.26976657 |
66 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.25512521 |
67 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.25497379 |
68 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21890843 |
69 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.20741689 |
70 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.18468347 |
71 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.18020152 |
72 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17704902 |
73 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.17203828 |
74 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16904669 |
75 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.15203683 |
76 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.15003197 |
77 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.14562598 |
78 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.14038576 |
79 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13843263 |
80 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.13077784 |
81 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12594938 |
82 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.11874579 |
83 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.10656201 |
84 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.10487694 |
85 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09544675 |
86 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.09387911 |
87 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.08832037 |
88 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.08128458 |
89 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08006216 |
90 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07703491 |
91 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.06855301 |
92 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.06591569 |
93 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.06278376 |
94 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.05922247 |
95 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05225076 |
96 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04493851 |
97 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04251264 |
98 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.03840395 |
99 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.03840395 |
100 | RXR_22108803_ChIP-Seq_LS180_Human | 1.03741322 |
101 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02564132 |
102 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02258651 |
103 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.01852602 |
104 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01213648 |
105 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00591764 |
106 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.99009888 |
107 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.98336624 |
108 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.98136968 |
109 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.97826262 |
110 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.96961502 |
111 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.96495031 |
112 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.95837084 |
113 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95388142 |
114 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94813192 |
115 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.94212119 |
116 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94159114 |
117 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93966754 |
118 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93922460 |
119 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.93804775 |
120 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93800599 |
121 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 0.93464709 |
122 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.93227189 |
123 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.93179972 |
124 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.93102919 |
125 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92689724 |
126 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92612073 |
127 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92564313 |
128 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92532119 |
129 | KDM2B_26808549_Chip-Seq_K562_Human | 0.91825545 |
130 | AR_19668381_ChIP-Seq_PC3_Human | 0.90221395 |
131 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89890173 |
132 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.88845866 |
133 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.88436471 |
134 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.87697425 |
135 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86935191 |
136 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86455362 |
137 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.86101136 |
138 | AR_25329375_ChIP-Seq_VCAP_Human | 0.84836376 |
139 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84016160 |
140 | STAT3_23295773_ChIP-Seq_U87_Human | 0.83468076 |
141 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.83419112 |
142 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.83265824 |
143 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82921331 |
144 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.82412523 |
145 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.82348238 |
146 | * ZNF274_21170338_ChIP-Seq_K562_Hela | 0.82024448 |
147 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81586620 |
148 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.80839229 |
149 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80302276 |
150 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.79436731 |
151 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79382545 |
152 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.78295197 |
153 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.77054940 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005365_abnormal_bile_salt | 4.29370480 |
2 | MP0005083_abnormal_biliary_tract | 4.05316274 |
3 | MP0002139_abnormal_hepatobiliary_system | 4.04661652 |
4 | MP0001666_abnormal_nutrient_absorption | 3.93595869 |
5 | MP0005085_abnormal_gallbladder_physiolo | 3.37808247 |
6 | MP0005360_urolithiasis | 3.22101042 |
7 | MP0005275_abnormal_skin_tensile | 3.06957502 |
8 | MP0003868_abnormal_feces_composition | 2.51054826 |
9 | MP0006054_spinal_hemorrhage | 2.48674821 |
10 | MP0003566_abnormal_cell_adhesion | 2.41146418 |
11 | MP0005220_abnormal_exocrine_pancreas | 2.39757040 |
12 | MP0010352_gastrointestinal_tract_polyps | 2.38977673 |
13 | MP0003252_abnormal_bile_duct | 2.36278093 |
14 | MP0001958_emphysema | 2.33716629 |
15 | MP0009780_abnormal_chondrocyte_physiolo | 2.32494877 |
16 | MP0004859_abnormal_synaptic_plasticity | 2.27226719 |
17 | MP0005058_abnormal_lysosome_morphology | 2.16568582 |
18 | MP0008875_abnormal_xenobiotic_pharmacok | 2.14076448 |
19 | MP0010329_abnormal_lipoprotein_level | 2.10653424 |
20 | MP0000569_abnormal_digit_pigmentation | 2.04686168 |
21 | MP0003950_abnormal_plasma_membrane | 2.04658159 |
22 | MP0003329_amyloid_beta_deposits | 1.94263291 |
23 | MP0003091_abnormal_cell_migration | 1.92301335 |
24 | MP0003195_calcinosis | 1.90358083 |
25 | MP0002877_abnormal_melanocyte_morpholog | 1.87476123 |
26 | MP0002166_altered_tumor_susceptibility | 1.80503908 |
27 | MP0010234_abnormal_vibrissa_follicle | 1.79814012 |
28 | MP0003690_abnormal_glial_cell | 1.78482096 |
29 | MP0008438_abnormal_cutaneous_collagen | 1.78023109 |
30 | MP0003279_aneurysm | 1.77486355 |
31 | MP0000604_amyloidosis | 1.72779438 |
32 | MP0002118_abnormal_lipid_homeostasis | 1.71479461 |
33 | MP0003300_gastrointestinal_ulcer | 1.60913734 |
34 | MP0004270_analgesia | 1.58595050 |
35 | MP0010368_abnormal_lymphatic_system | 1.56327360 |
36 | MP0005332_abnormal_amino_acid | 1.55639214 |
37 | MP0005164_abnormal_response_to | 1.51070277 |
38 | MP0005084_abnormal_gallbladder_morpholo | 1.50618325 |
39 | MP0000920_abnormal_myelination | 1.48712215 |
40 | MP0002909_abnormal_adrenal_gland | 1.45518138 |
41 | MP0009840_abnormal_foam_cell | 1.44213844 |
42 | MP0003172_abnormal_lysosome_physiology | 1.43421556 |
43 | MP0003635_abnormal_synaptic_transmissio | 1.43129207 |
44 | MP0003705_abnormal_hypodermis_morpholog | 1.42516437 |
45 | MP0005257_abnormal_intraocular_pressure | 1.40015187 |
46 | MP0002138_abnormal_hepatobiliary_system | 1.39531836 |
47 | MP0005409_darkened_coat_color | 1.38898812 |
48 | MP0002060_abnormal_skin_morphology | 1.38725594 |
49 | MP0010678_abnormal_skin_adnexa | 1.37402574 |
50 | MP0003183_abnormal_peptide_metabolism | 1.36268295 |
51 | MP0009384_cardiac_valve_regurgitation | 1.33903072 |
52 | MP0002693_abnormal_pancreas_physiology | 1.31854897 |
53 | MP0000013_abnormal_adipose_tissue | 1.31264195 |
54 | MP0005503_abnormal_tendon_morphology | 1.26097561 |
55 | MP0005451_abnormal_body_composition | 1.24662474 |
56 | MP0003656_abnormal_erythrocyte_physiolo | 1.24561081 |
57 | MP0004043_abnormal_pH_regulation | 1.24296156 |
58 | MP0002006_tumorigenesis | 1.22928632 |
59 | MP0005535_abnormal_body_temperature | 1.22813583 |
60 | MP0003191_abnormal_cellular_cholesterol | 1.22800855 |
61 | MP0002090_abnormal_vision | 1.21955116 |
62 | MP0004264_abnormal_extraembryonic_tissu | 1.20947870 |
63 | MP0002009_preneoplasia | 1.19584334 |
64 | MP0002295_abnormal_pulmonary_circulatio | 1.17728646 |
65 | MP0002168_other_aberrant_phenotype | 1.17112857 |
66 | MP0005023_abnormal_wound_healing | 1.16638891 |
67 | MP0002064_seizures | 1.16265016 |
68 | MP0005408_hypopigmentation | 1.16231845 |
69 | MP0000767_abnormal_smooth_muscle | 1.15439612 |
70 | MP0000003_abnormal_adipose_tissue | 1.15157954 |
71 | MP0008004_abnormal_stomach_pH | 1.15154637 |
72 | MP0003941_abnormal_skin_development | 1.14583117 |
73 | MP0004883_abnormal_blood_vessel | 1.13908078 |
74 | MP0003828_pulmonary_edema | 1.12001881 |
75 | MP0004130_abnormal_muscle_cell | 1.11771231 |
76 | * MP0001944_abnormal_pancreas_morphology | 1.10718555 |
77 | MP0003880_abnormal_central_pattern | 1.09311987 |
78 | MP0002078_abnormal_glucose_homeostasis | 1.09210567 |
79 | MP0009745_abnormal_behavioral_response | 1.05031739 |
80 | MP0002998_abnormal_bone_remodeling | 1.03960683 |
81 | MP0003959_abnormal_lean_body | 1.03599876 |
82 | MP0003075_altered_response_to | 1.03223491 |
83 | MP0002876_abnormal_thyroid_physiology | 1.02480040 |
84 | MP0003633_abnormal_nervous_system | 1.01953578 |
85 | MP0002063_abnormal_learning/memory/cond | 1.01652598 |
86 | * MP0000609_abnormal_liver_physiology | 1.00741351 |
87 | MP0003453_abnormal_keratinocyte_physiol | 1.00729249 |
88 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.00150763 |
89 | MP0004782_abnormal_surfactant_physiolog | 0.98253772 |
90 | MP0005448_abnormal_energy_balance | 0.94817352 |
91 | MP0001664_abnormal_digestion | 0.94653036 |
92 | MP0009643_abnormal_urine_homeostasis | 0.94430678 |
93 | MP0000371_diluted_coat_color | 0.93658659 |
94 | MP0003045_fibrosis | 0.93305602 |
95 | MP0003634_abnormal_glial_cell | 0.91828983 |
96 | MP0000427_abnormal_hair_cycle | 0.91320905 |
97 | MP0005623_abnormal_meninges_morphology | 0.90813952 |
98 | MP0003724_increased_susceptibility_to | 0.90452971 |
99 | MP0005076_abnormal_cell_differentiation | 0.90440684 |
100 | MP0005310_abnormal_salivary_gland | 0.88595138 |
101 | MP0001915_intracranial_hemorrhage | 0.86501552 |
102 | MP0004858_abnormal_nervous_system | 0.86018064 |
103 | MP0002272_abnormal_nervous_system | 0.85706840 |
104 | MP0001765_abnormal_ion_homeostasis | 0.85613984 |
105 | MP0005165_increased_susceptibility_to | 0.85243885 |
106 | MP0000685_abnormal_immune_system | 0.85058850 |
107 | MP0010386_abnormal_urinary_bladder | 0.83326915 |
108 | MP0002896_abnormal_bone_mineralization | 0.83187953 |
109 | MP0001501_abnormal_sleep_pattern | 0.81774849 |
110 | MP0004947_skin_inflammation | 0.80384073 |
111 | MP0002229_neurodegeneration | 0.80164996 |
112 | MP0001486_abnormal_startle_reflex | 0.80133751 |
113 | MP0002133_abnormal_respiratory_system | 0.80012507 |
114 | MP0005388_respiratory_system_phenotype | 0.80012507 |
115 | MP0005319_abnormal_enzyme/_coenzyme | 0.79909994 |
116 | MP0004885_abnormal_endolymph | 0.78328836 |
117 | MP0003303_peritoneal_inflammation | 0.78223968 |
118 | MP0002254_reproductive_system_inflammat | 0.77919094 |
119 | MP0002822_catalepsy | 0.77653438 |
120 | MP0009046_muscle_twitch | 0.77567069 |
121 | MP0001177_atelectasis | 0.76831574 |
122 | MP0002837_dystrophic_cardiac_calcinosis | 0.76517395 |
123 | MP0000249_abnormal_blood_vessel | 0.75995546 |
124 | MP0006082_CNS_inflammation | 0.75395146 |
125 | MP0002971_abnormal_brown_adipose | 0.74953426 |
126 | MP0005375_adipose_tissue_phenotype | 0.74921638 |
127 | MP0001299_abnormal_eye_distance/ | 0.74610582 |
128 | MP0008961_abnormal_basal_metabolism | 0.74117591 |
129 | MP0003631_nervous_system_phenotype | 0.73959238 |
130 | MP0001533_abnormal_skeleton_physiology | 0.73822197 |
131 | MP0004484_altered_response_of | 0.73659783 |
132 | MP0004185_abnormal_adipocyte_glucose | 0.73158931 |
133 | MP0002572_abnormal_emotion/affect_behav | 0.72931350 |
134 | MP0005464_abnormal_platelet_physiology | 0.72660713 |
135 | MP0002928_abnormal_bile_duct | 0.72614708 |
136 | MP0001661_extended_life_span | 0.72318893 |
137 | MP0003283_abnormal_digestive_organ | 0.71496798 |
138 | MP0001243_abnormal_dermal_layer | 0.71474403 |
139 | MP0005167_abnormal_blood-brain_barrier | 0.70535882 |
140 | MP0003795_abnormal_bone_structure | 0.69827684 |
141 | MP0001851_eye_inflammation | 0.69420452 |
142 | MP0004084_abnormal_cardiac_muscle | 0.69364427 |
143 | MP0001502_abnormal_circadian_rhythm | 0.69040147 |
144 | MP0002796_impaired_skin_barrier | 0.69036485 |
145 | MP0001879_abnormal_lymphatic_vessel | 0.68574218 |
146 | MP0000538_abnormal_urinary_bladder | 0.68104296 |
147 | MP0004272_abnormal_basement_membrane | 0.67940809 |
148 | MP0005334_abnormal_fat_pad | 0.67336987 |
149 | MP0000639_abnormal_adrenal_gland | 0.66639518 |
150 | MP0001216_abnormal_epidermal_layer | 0.66626754 |
151 | MP0001542_abnormal_bone_strength | 0.66372636 |
152 | MP0005595_abnormal_vascular_smooth | 0.64376079 |
153 | MP0000462_abnormal_digestive_system | 0.63557947 |
154 | MP0000383_abnormal_hair_follicle | 0.63442096 |
155 | MP0003638_abnormal_response/metabolism_ | 0.63079524 |
156 | MP0004924_abnormal_behavior | 0.62833473 |
157 | MP0005386_behavior/neurological_phenoty | 0.62833473 |
158 | MP0003953_abnormal_hormone_level | 0.62684225 |
159 | MP0002734_abnormal_mechanical_nocicepti | 0.61860436 |
160 | MP0003632_abnormal_nervous_system | 0.61771366 |
161 | MP0001440_abnormal_grooming_behavior | 0.61476329 |
162 | MP0005551_abnormal_eye_electrophysiolog | 0.59363477 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Premature rupture of membranes (HP:0001788) | 4.05191442 |
2 | Deep venous thrombosis (HP:0002625) | 3.88220394 |
3 | Arterial tortuosity (HP:0005116) | 3.87012082 |
4 | Vascular tortuosity (HP:0004948) | 3.73202204 |
5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.69698286 |
6 | Aortic dissection (HP:0002647) | 3.63873699 |
7 | Neurofibrillary tangles (HP:0002185) | 3.52229311 |
8 | Protrusio acetabuli (HP:0003179) | 3.50983055 |
9 | Intrahepatic cholestasis (HP:0001406) | 3.41626863 |
10 | Abnormality of the common coagulation pathway (HP:0010990) | 3.39394012 |
11 | Xanthomatosis (HP:0000991) | 3.38671841 |
12 | Cerebral inclusion bodies (HP:0100314) | 3.33219805 |
13 | Abnormality of the intrinsic pathway (HP:0010989) | 3.29117295 |
14 | Fat malabsorption (HP:0002630) | 3.14152889 |
15 | Hyperlipoproteinemia (HP:0010980) | 3.13721585 |
16 | Ketosis (HP:0001946) | 3.09789851 |
17 | Abnormality of glycolipid metabolism (HP:0010969) | 3.06152836 |
18 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.06152836 |
19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.06152836 |
20 | Osteolytic defects of the hand bones (HP:0009699) | 3.05234994 |
21 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.05234994 |
22 | Aortic aneurysm (HP:0004942) | 3.05037885 |
23 | Supranuclear gaze palsy (HP:0000605) | 3.00081409 |
24 | Ketoacidosis (HP:0001993) | 2.97543075 |
25 | Dysostosis multiplex (HP:0000943) | 2.93328895 |
26 | Complement deficiency (HP:0004431) | 2.74445999 |
27 | Spondylolisthesis (HP:0003302) | 2.70498937 |
28 | Steatorrhea (HP:0002570) | 2.70283568 |
29 | Prolonged partial thromboplastin time (HP:0003645) | 2.65961136 |
30 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.60787775 |
31 | Mucopolysacchariduria (HP:0008155) | 2.60787775 |
32 | Atrophic scars (HP:0001075) | 2.58219706 |
33 | Tetraparesis (HP:0002273) | 2.41551020 |
34 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.40278502 |
35 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.38072716 |
36 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.38072716 |
37 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.38072716 |
38 | Epidermoid cyst (HP:0200040) | 2.37841846 |
39 | Asymmetry of the thorax (HP:0001555) | 2.37826105 |
40 | Vertebral compression fractures (HP:0002953) | 2.37005705 |
41 | Hypoglycemic coma (HP:0001325) | 2.34938129 |
42 | Skin nodule (HP:0200036) | 2.34150649 |
43 | Myocardial infarction (HP:0001658) | 2.32886148 |
44 | Increased cerebral lipofuscin (HP:0011813) | 2.32132038 |
45 | Gout (HP:0001997) | 2.30499239 |
46 | Wormian bones (HP:0002645) | 2.29476797 |
47 | Papillary thyroid carcinoma (HP:0002895) | 2.28504432 |
48 | Hypoglycemic seizures (HP:0002173) | 2.27634069 |
49 | Peritonitis (HP:0002586) | 2.27048593 |
50 | Follicular hyperkeratosis (HP:0007502) | 2.26875360 |
51 | Dysmetric saccades (HP:0000641) | 2.24554410 |
52 | Conjugated hyperbilirubinemia (HP:0002908) | 2.24495765 |
53 | Cervical subluxation (HP:0003308) | 2.23700103 |
54 | Turricephaly (HP:0000262) | 2.19364279 |
55 | Dilatation of the ascending aorta (HP:0005111) | 2.19055137 |
56 | Flat acetabular roof (HP:0003180) | 2.16797520 |
57 | Cerebral aneurysm (HP:0004944) | 2.16057400 |
58 | Retinal atrophy (HP:0001105) | 2.12342272 |
59 | Glomerulonephritis (HP:0000099) | 2.07768575 |
60 | Intention tremor (HP:0002080) | 2.07012128 |
61 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.06537973 |
62 | Ovoid vertebral bodies (HP:0003300) | 2.06195187 |
63 | Hypobetalipoproteinemia (HP:0003563) | 2.05775995 |
64 | Protuberant abdomen (HP:0001538) | 2.05682357 |
65 | Hypoalphalipoproteinemia (HP:0003233) | 2.04709784 |
66 | Amyloidosis (HP:0011034) | 2.02544517 |
67 | Right ventricular cardiomyopathy (HP:0011663) | 2.02434679 |
68 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.01541971 |
69 | Soft skin (HP:0000977) | 2.00718801 |
70 | Asymmetric septal hypertrophy (HP:0001670) | 2.00705241 |
71 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.99501041 |
72 | Infantile muscular hypotonia (HP:0008947) | 1.98866939 |
73 | Insidious onset (HP:0003587) | 1.97750663 |
74 | Termporal pattern (HP:0011008) | 1.97750663 |
75 | Systemic lupus erythematosus (HP:0002725) | 1.97227907 |
76 | Subacute progressive viral hepatitis (HP:0006572) | 1.97121670 |
77 | Action tremor (HP:0002345) | 1.96829870 |
78 | Hematochezia (HP:0002573) | 1.96724835 |
79 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.96510901 |
80 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.96188605 |
81 | Ankyloglossia (HP:0010296) | 1.94637223 |
82 | Vacuolated lymphocytes (HP:0001922) | 1.93791179 |
83 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.92582209 |
84 | Coarse hair (HP:0002208) | 1.91486298 |
85 | Hypolipoproteinemia (HP:0010981) | 1.91114063 |
86 | Mitral stenosis (HP:0001718) | 1.90213040 |
87 | Blue sclerae (HP:0000592) | 1.89507648 |
88 | Macroorchidism (HP:0000053) | 1.89310998 |
89 | Striae distensae (HP:0001065) | 1.88983560 |
90 | Fragile skin (HP:0001030) | 1.88498233 |
91 | Mitral valve prolapse (HP:0001634) | 1.87876664 |
92 | Status epilepticus (HP:0002133) | 1.87597762 |
93 | Hyperammonemia (HP:0001987) | 1.87271251 |
94 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.87228781 |
95 | Abnormal foot bone ossification (HP:0010675) | 1.86874886 |
96 | Thin bony cortex (HP:0002753) | 1.84796247 |
97 | Sensorimotor neuropathy (HP:0007141) | 1.83399428 |
98 | Visual hallucinations (HP:0002367) | 1.83298254 |
99 | Absent frontal sinuses (HP:0002688) | 1.82619066 |
100 | Syringomyelia (HP:0003396) | 1.79765912 |
101 | Spinal cord lesions (HP:0100561) | 1.79765912 |
102 | Buphthalmos (HP:0000557) | 1.79432495 |
103 | Gingival bleeding (HP:0000225) | 1.77885543 |
104 | Ankle contracture (HP:0006466) | 1.76479204 |
105 | Neuronal loss in central nervous system (HP:0002529) | 1.76431186 |
106 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.76265505 |
107 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.76265505 |
108 | Joint hemorrhage (HP:0005261) | 1.76223394 |
109 | Short nail (HP:0001799) | 1.76173800 |
110 | Periodontitis (HP:0000704) | 1.76091499 |
111 | Focal seizures (HP:0007359) | 1.75082694 |
112 | Abnormality of proline metabolism (HP:0010907) | 1.74979294 |
113 | Hydroxyprolinuria (HP:0003080) | 1.74979294 |
114 | Spastic gait (HP:0002064) | 1.74521150 |
115 | EEG with generalized epileptiform discharges (HP:0011198) | 1.74518234 |
116 | Cardiovascular calcification (HP:0011915) | 1.73824517 |
117 | Overgrowth (HP:0001548) | 1.73749485 |
118 | Epileptiform EEG discharges (HP:0011182) | 1.73658011 |
119 | Postural instability (HP:0002172) | 1.73281611 |
120 | Dysmetria (HP:0001310) | 1.72281350 |
121 | Hypsarrhythmia (HP:0002521) | 1.72040762 |
122 | Hypercholesterolemia (HP:0003124) | 1.72027780 |
123 | Type II lissencephaly (HP:0007260) | 1.71296933 |
124 | Hyperextensible skin (HP:0000974) | 1.70942511 |
125 | Hyperglycinemia (HP:0002154) | 1.70659702 |
126 | Abdominal distention (HP:0003270) | 1.70369822 |
127 | Nephritis (HP:0000123) | 1.69916924 |
128 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.69621206 |
129 | Abnormality of the corticospinal tract (HP:0002492) | 1.69115722 |
130 | Axonal loss (HP:0003447) | 1.68817623 |
131 | Testicular neoplasm (HP:0010788) | 1.68796844 |
132 | Curly hair (HP:0002212) | 1.68724675 |
133 | Exocrine pancreatic insufficiency (HP:0001738) | 1.68494313 |
134 | Abnormality of complement system (HP:0005339) | 1.68045765 |
135 | Vascular calcification (HP:0004934) | 1.68019940 |
136 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.67979398 |
137 | Abnormality of glycine metabolism (HP:0010895) | 1.67979398 |
138 | Global brain atrophy (HP:0002283) | 1.67788835 |
139 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.67552162 |
140 | Abnormality of oral frenula (HP:0000190) | 1.67530966 |
141 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.67445548 |
142 | Bladder diverticulum (HP:0000015) | 1.66503238 |
143 | Akinesia (HP:0002304) | 1.64815428 |
144 | Esophageal varix (HP:0002040) | 1.64554965 |
145 | Thickened calvaria (HP:0002684) | 1.64300459 |
146 | Thyroid carcinoma (HP:0002890) | 1.64088479 |
147 | Abnormality of the lumbar spine (HP:0100712) | 1.63763999 |
148 | Pancreatitis (HP:0001733) | 1.63719287 |
149 | Loss of speech (HP:0002371) | 1.63116947 |
150 | Abnormality of carpal bone ossification (HP:0006257) | 1.61457418 |
151 | Agitation (HP:0000713) | 1.61366982 |
152 | Hyperventilation (HP:0002883) | 1.60986083 |
153 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.60633865 |
154 | Scanning speech (HP:0002168) | 1.60601321 |
155 | Cerebral hemorrhage (HP:0001342) | 1.60497970 |
156 | Abnormality of the Achilles tendon (HP:0005109) | 1.60290175 |
157 | Abnormality of purine metabolism (HP:0004352) | 1.59857690 |
158 | Abnormality of the acetabulum (HP:0003170) | 1.59495529 |
159 | Increased CSF protein (HP:0002922) | 1.58662566 |
160 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.58555418 |
161 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.58260950 |
162 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.58260950 |
163 | Malnutrition (HP:0004395) | 1.58207096 |
164 | Congenital glaucoma (HP:0001087) | 1.56823604 |
165 | Generalized tonic-clonic seizures (HP:0002069) | 1.55381469 |
166 | Symptomatic seizures (HP:0011145) | 1.54269729 |
167 | Aneurysm (HP:0002617) | 1.54132009 |
168 | Potter facies (HP:0002009) | 1.51960596 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 3.98465037 |
2 | EIF2AK3 | 2.82997275 |
3 | AKT3 | 2.77811057 |
4 | NEK9 | 2.75294054 |
5 | BCKDK | 2.74829580 |
6 | TAOK3 | 2.48932139 |
7 | INSRR | 2.29637364 |
8 | TRPM7 | 2.24344134 |
9 | TRIB3 | 2.22092186 |
10 | NTRK3 | 2.12420582 |
11 | MAP3K2 | 2.09153470 |
12 | FRK | 2.03613440 |
13 | TGFBR2 | 1.94971517 |
14 | NTRK1 | 1.91634866 |
15 | EPHB1 | 1.89289697 |
16 | SIK1 | 1.84119818 |
17 | EPHA4 | 1.78200359 |
18 | KSR2 | 1.77871843 |
19 | RIPK1 | 1.75940771 |
20 | PRPF4B | 1.73529211 |
21 | MAP3K9 | 1.71509104 |
22 | MAP3K12 | 1.64316042 |
23 | DAPK2 | 1.59174446 |
24 | MYLK | 1.58431480 |
25 | STK39 | 1.55579215 |
26 | TYK2 | 1.51989873 |
27 | MAP3K4 | 1.50413564 |
28 | EIF2AK1 | 1.49021599 |
29 | CAMK1G | 1.48817144 |
30 | RIPK4 | 1.41889909 |
31 | MAP3K13 | 1.41824921 |
32 | PKN2 | 1.38087287 |
33 | BMPR2 | 1.36979853 |
34 | STK24 | 1.32941516 |
35 | RET | 1.32837789 |
36 | FGFR2 | 1.25710973 |
37 | MAP2K4 | 1.24901995 |
38 | YES1 | 1.23653837 |
39 | SGK2 | 1.21097668 |
40 | PAK6 | 1.20900935 |
41 | ERBB3 | 1.19542503 |
42 | SCYL2 | 1.16895226 |
43 | MET | 1.11121162 |
44 | DDR2 | 1.10718889 |
45 | PDGFRA | 1.09962170 |
46 | WNK4 | 1.09517973 |
47 | PTK6 | 1.09501458 |
48 | CAMK1D | 1.08828786 |
49 | MAP3K3 | 1.07220807 |
50 | CAMKK1 | 1.06856930 |
51 | EEF2K | 1.05676998 |
52 | PAK3 | 1.05108744 |
53 | MELK | 1.00898091 |
54 | PDPK1 | 0.99759690 |
55 | PRKCH | 0.99757595 |
56 | OXSR1 | 0.98332561 |
57 | LATS1 | 0.96863329 |
58 | LATS2 | 0.96725394 |
59 | PRKD3 | 0.91794082 |
60 | MST1R | 0.90981797 |
61 | PDGFRB | 0.90622527 |
62 | JAK1 | 0.89633804 |
63 | PAK4 | 0.89610009 |
64 | CDC42BPA | 0.89570250 |
65 | CDK5 | 0.88844037 |
66 | MAP3K7 | 0.88076923 |
67 | FER | 0.87948571 |
68 | FGFR4 | 0.87338078 |
69 | MAP3K1 | 0.86059337 |
70 | PTK2 | 0.84884719 |
71 | STK38L | 0.84619042 |
72 | MST4 | 0.83435249 |
73 | FES | 0.79104508 |
74 | ACVR1B | 0.78673134 |
75 | MARK1 | 0.78243903 |
76 | WNK1 | 0.77965538 |
77 | MINK1 | 0.77242508 |
78 | PDK1 | 0.76147957 |
79 | BRD4 | 0.75494900 |
80 | EPHA3 | 0.74949067 |
81 | MAP2K1 | 0.73954148 |
82 | NLK | 0.73923756 |
83 | PIK3CA | 0.73662412 |
84 | MAPK7 | 0.73453399 |
85 | ROCK2 | 0.72143452 |
86 | IRAK2 | 0.72112538 |
87 | JAK2 | 0.72045834 |
88 | PKN1 | 0.72030910 |
89 | FGR | 0.71522771 |
90 | CDK12 | 0.71187613 |
91 | CAMKK2 | 0.70429288 |
92 | STK3 | 0.70189902 |
93 | MAPKAPK3 | 0.69954786 |
94 | CDK6 | 0.69745974 |
95 | IRAK3 | 0.69616773 |
96 | PTK2B | 0.69026056 |
97 | TNIK | 0.68744636 |
98 | MAP2K2 | 0.67531745 |
99 | TBK1 | 0.65464930 |
100 | SGK494 | 0.65282252 |
101 | SGK223 | 0.65282252 |
102 | EPHA2 | 0.65161119 |
103 | BMX | 0.63655414 |
104 | TYRO3 | 0.62553102 |
105 | PRKCZ | 0.61808668 |
106 | ICK | 0.61561894 |
107 | PRKG2 | 0.61109097 |
108 | PAK2 | 0.58002505 |
109 | BLK | 0.57990953 |
110 | FYN | 0.57917631 |
111 | PHKG1 | 0.57225887 |
112 | PHKG2 | 0.57225887 |
113 | CAMK2D | 0.56795395 |
114 | CAMK2A | 0.56733653 |
115 | STK38 | 0.56238968 |
116 | PRKD1 | 0.56045407 |
117 | MARK2 | 0.55477858 |
118 | CAMK2B | 0.54719131 |
119 | LMTK2 | 0.54036517 |
120 | CSNK1G2 | 0.52946745 |
121 | HIPK2 | 0.52805617 |
122 | MAP3K14 | 0.52556613 |
123 | PRKCE | 0.51283878 |
124 | RPS6KB1 | 0.51191330 |
125 | SGK3 | 0.51030290 |
126 | MAP3K5 | 0.50922235 |
127 | PRKCQ | 0.50712627 |
128 | IKBKE | 0.50147435 |
129 | SGK1 | 0.50044154 |
130 | MOS | 0.48213900 |
131 | TAF1 | 0.48157515 |
132 | ZAP70 | 0.47425631 |
133 | MAP3K6 | 0.46626991 |
134 | NEK6 | 0.46608715 |
135 | GRK5 | 0.46542827 |
136 | MAP2K3 | 0.46109733 |
137 | MAPK15 | 0.46106779 |
138 | CSK | 0.45740562 |
139 | FGFR3 | 0.45575182 |
140 | PRKAA2 | 0.45349179 |
141 | MAP2K7 | 0.45144967 |
142 | PIK3CG | 0.44688458 |
143 | JAK3 | 0.44535001 |
144 | TTN | 0.44111037 |
145 | SIK2 | 0.43382288 |
146 | CAMK2G | 0.43089386 |
147 | ERBB4 | 0.42101471 |
148 | MTOR | 0.41567549 |
149 | DMPK | 0.41229007 |
150 | KSR1 | 0.40987267 |
151 | IGF1R | 0.40061670 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.92313735 |
2 | Pancreatic secretion_Homo sapiens_hsa04972 | 2.32373706 |
3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.22921488 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.92870863 |
5 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.90549319 |
6 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.73150223 |
7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.67520463 |
8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.61990590 |
9 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.53800865 |
10 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.53053407 |
11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.47041780 |
12 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.46374585 |
13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.39025710 |
14 | Protein export_Homo sapiens_hsa03060 | 1.38339217 |
15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.36260133 |
16 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.36235535 |
17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.32778010 |
18 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.32089796 |
19 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.31946271 |
20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.30165711 |
21 | Focal adhesion_Homo sapiens_hsa04510 | 1.29658889 |
22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.28924626 |
23 | Bile secretion_Homo sapiens_hsa04976 | 1.25546092 |
24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.25010416 |
25 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.21078957 |
26 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.19397081 |
27 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.18160311 |
28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.14565272 |
29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.13912718 |
30 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12916284 |
31 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.11525356 |
32 | Insulin secretion_Homo sapiens_hsa04911 | 1.10861529 |
33 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.07263934 |
34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.04225325 |
35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.03209995 |
36 | GABAergic synapse_Homo sapiens_hsa04727 | 1.03154639 |
37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.00591283 |
38 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.96213557 |
39 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.92787126 |
40 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.92210284 |
41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.91569786 |
42 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.89652067 |
43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.88866081 |
44 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.87891654 |
45 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87220403 |
46 | Prostate cancer_Homo sapiens_hsa05215 | 0.86516267 |
47 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86109639 |
48 | Salivary secretion_Homo sapiens_hsa04970 | 0.85895822 |
49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.84899226 |
50 | Histidine metabolism_Homo sapiens_hsa00340 | 0.84876194 |
51 | Lysosome_Homo sapiens_hsa04142 | 0.84819178 |
52 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.84194593 |
53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.83796295 |
54 | Renin secretion_Homo sapiens_hsa04924 | 0.83792289 |
55 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.83463633 |
56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83343766 |
57 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.81803864 |
58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.81659268 |
59 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.81621118 |
60 | Adherens junction_Homo sapiens_hsa04520 | 0.81140891 |
61 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.80561962 |
62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80204187 |
63 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.79419266 |
64 | Long-term potentiation_Homo sapiens_hsa04720 | 0.79348228 |
65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.78477599 |
66 | Peroxisome_Homo sapiens_hsa04146 | 0.78408756 |
67 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.76755287 |
68 | Retinol metabolism_Homo sapiens_hsa00830 | 0.76667716 |
69 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.76523081 |
70 | Circadian rhythm_Homo sapiens_hsa04710 | 0.76398458 |
71 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.76269433 |
72 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.75776365 |
73 | Circadian entrainment_Homo sapiens_hsa04713 | 0.75659371 |
74 | Prion diseases_Homo sapiens_hsa05020 | 0.74679493 |
75 | ABC transporters_Homo sapiens_hsa02010 | 0.74490740 |
76 | Nicotine addiction_Homo sapiens_hsa05033 | 0.74011482 |
77 | Hepatitis C_Homo sapiens_hsa05160 | 0.73848849 |
78 | Cocaine addiction_Homo sapiens_hsa05030 | 0.73784600 |
79 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.73503714 |
80 | Mineral absorption_Homo sapiens_hsa04978 | 0.72620348 |
81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72240330 |
82 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.72010368 |
83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71448035 |
84 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.71030486 |
85 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.70436230 |
86 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.69963862 |
87 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.68555944 |
88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68344766 |
89 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.68163115 |
90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.67230929 |
91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.66057192 |
92 | Pertussis_Homo sapiens_hsa05133 | 0.65842688 |
93 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.65457187 |
94 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65175190 |
95 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.64693386 |
96 | Phagosome_Homo sapiens_hsa04145 | 0.64327003 |
97 | Platelet activation_Homo sapiens_hsa04611 | 0.64185253 |
98 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.63892662 |
99 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.63838387 |
100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.63153948 |
101 | Morphine addiction_Homo sapiens_hsa05032 | 0.63120039 |
102 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62555420 |
103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.61783833 |
104 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.61363899 |
105 | Malaria_Homo sapiens_hsa05144 | 0.61332058 |
106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60281956 |
107 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59047926 |
108 | Insulin resistance_Homo sapiens_hsa04931 | 0.56539036 |
109 | Hepatitis B_Homo sapiens_hsa05161 | 0.56154762 |
110 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55353858 |
111 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54637384 |
112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54172989 |
113 | Tuberculosis_Homo sapiens_hsa05152 | 0.53493717 |
114 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.53327933 |
115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52455718 |
116 | Long-term depression_Homo sapiens_hsa04730 | 0.52167059 |
117 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51364120 |
118 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51185760 |
119 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50965033 |
120 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.50169345 |
121 | Influenza A_Homo sapiens_hsa05164 | 0.49641694 |
122 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.49107259 |
123 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.48906864 |
124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48890427 |
125 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.48531949 |
126 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.48198060 |
127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47729488 |
128 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.47500073 |
129 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.47242371 |
130 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46729887 |
131 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45883236 |
132 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.45682004 |
133 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.45280978 |
134 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.45150374 |
135 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.44227813 |
136 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.43881725 |
137 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.43149506 |
138 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42922381 |
139 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.42872186 |
140 | Other glycan degradation_Homo sapiens_hsa00511 | 0.42238359 |
141 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.40585242 |
142 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.39498184 |
143 | Glioma_Homo sapiens_hsa05214 | 0.39012386 |
144 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38554896 |
145 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38424957 |
146 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.37675419 |
147 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.37420286 |
148 | Amoebiasis_Homo sapiens_hsa05146 | 0.37407486 |
149 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36278772 |
150 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36132693 |
151 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.35861749 |